Remove solutions participant-identification
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

There are 5 guiding principles for defining quality that should inform DCTs: Have we enrolled the right participants according to the protocol with adequate consent? Did participants receive the assigned treatment and did they stay on the treatment? What we often do not think about is verifying the identity of the participant.

article thumbnail

Transforming Your Informed Consent Process

Cloudbyz

Here are some of the hot features that most organizations are currently looking for in their eConsent solution: User Friendly. A user friendly eConsent form provides a seamless experience for the participants. Configuring lag time allows participants to take their time in understanding the study. Authentication. Query handling.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Blazing a Trail in Clinical Research

ACRP blog

Complexity in trial design increases resource demands at trial sites, burdens study participants, and creates costlier, longer development cycles (Getz, Tufts Center for the Study of Drug Development). AI has the potential to optimize patient recruitment strategies by analyzing vast datasets to identify eligible participants.

article thumbnail

The next phase of decentralisation in clinical trials

Pharmaceutical Technology

The result is an improved experience for patients, whose participation no longer rests on long journeys to and from sites. Decentralisation has the potential to solve a lot of these challenges, particularly around participation rates but also importantly around diversity.”

article thumbnail

A New, Automated Approach to Patient Identification for Clinical Trials

ACRP blog

3 While many aspects of the clinical trial process have become more streamlined, the patient identification process still largely relies on inefficient practices. The solution runs safety rules in the background that automatically populate a safety report based on trial needs. Tufts Center for the Study of Drug Development.

article thumbnail

Pharmacovigilance in Clinical Trials: Safeguarding Participant Safety and Ensuring Data Integrity

Cloudbyz

However, ensuring participant safety is paramount throughout the trial process. Pharmacovigilance plays a critical role in monitoring adverse events, collecting safety data, and reporting requirements to protect participants.

article thumbnail

IN FOCUS: Walgreens

Pharmaceutical Technology

Using a tech-enabled approach to patient identification and creating a large registry of clinical trial participants, Walgreens will reduce the time it takes to match eligible patients to clinical trials and provide another offering for patients with complex or chronic conditions in their care journey.

Pharmacy 130